Intrinsic Value of S&P & Nasdaq Contact Us

Exactus, Inc. EXDI OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Exactus, Inc. (EXDI) reported total assets of $24.11M and total liabilities of $15.8M for quarter ending 2021-09-30, resulting in total equity of $8.32M.

The company held $3.65M in cash and short-term investments. Total debt stood at $11.28M, with net debt of $11.26M. The Debt-to-Equity (D/E) ratio was 1.36 (moderate).

Current ratio is 0.72, which may signal tight short-term liquidity. Interest coverage is -7.2x (weak).

Criteria supported by this page:

  • HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (15/100) — Total assets $24.11M and equity $8.32M support the company's competitive scale

Overall SharesGrow Score: 16/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
17/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
15/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Exactus, Inc. Balance Sheet History
Metric Q3 FY2021 Q2 FY2021 Q1 FY2021 Q4 FY2020
Total Assets $24.11M$23.64M$58.06K$-2.82M
Total Liabilities $15.8M$11.62M$3.62M$4.9M
Total Debt $11.28M$9.42M$840.14K$130.34K
Cash & Investments $3.65M$6.14M$19.72K$25.14K
Total Stockholders Equity $8.32M$12.02M$-1.54M$-3.02M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message